Author Correction: Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma

• Nancy S. Younis,
• Amal M. H. Ghanim,
• Sameh Saber

Affiliations

Nancy S. Younis

Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University

Amal M. H. Ghanim

Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology

Sameh Saber

Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology